BioSphings AG.
Link ID 246357
Title BioSphings AG.
Url http://www.biosphings.com/
Description Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.
Category Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
Keywords
Date Jul 19, 2006
Contact Name
Email
Add to My Favorite   Refer it to Friend   Report Broken Link  


 Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
1. Gemac
  Researching diagnostics and drug candidates for the treatment of amyotrophic lateral and multiple sclerosis, as well as autoimmune diseases, including anti-idiotypic antibodies. Includes overview of corporation in Cenon, France.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


2. Synaptic Pharmaceutical Corp.
  Applies human receptor-targeted drug design technology to discover and clone genes and to design G protein-coupled receptor agonist and antagonists. Based in Paramus, New Jersey. (Nasdaq: SNAP)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


3. Nephros Therapeutics, Inc.
  Specialist in the design, development, and marketing of human cell replacement therapy systems, targeting inflammatory disease. Includes directions to research labs at Ann Arbor, Michigan, and corporate offices in Lincoln, Rhode Island.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


4. Rib-X Pharmaceuticals Inc.
  Structure-based drug design start-up, specializing in the ribosome as a target, and bacterial antibiotic resistance. Includes mechanisms of action, glossary, careers, corporate news and contacts and directions in New Haven, Connecticut.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


5. Genelabs Technologies, Inc.
  Discovers, develops and commercializes therapies for systemic lupus erythematosus, viral diseases and cancer. Located in Redwood City, California.(Nasdaq: GNLB)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development




Home      New Listings      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing     Disclaimer
Copyright © internet-directory.com 1999-2023

Sponsors